Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

BCG vaccine/emapalumab

Disseminated tuberculosis, Bcgitis and off-label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tucci F, et al. Successful rescue with emapalumab in an ADA-scid patient with refractory hemophagocytic lymphohistiocytosis (HLH)-related graft failure and disseminated Bcgitis. HemaSphere 4 (Suppl. 1): 1033-1034 abstr. PB2305, Jun 2020. Available from: URL: http://doi.org/10.1097/HS9.0000000000000404 [abstract] Tucci F, et al. Successful rescue with emapalumab in an ADA-scid patient with refractory hemophagocytic lymphohistiocytosis (HLH)-related graft failure and disseminated Bcgitis. HemaSphere 4 (Suppl. 1): 1033-1034 abstr. PB2305, Jun 2020. Available from: URL: http://​doi.​org/​10.​1097/​HS9.​0000000000000404​ [abstract]
Metadaten
Titel
BCG vaccine/emapalumab
Disseminated tuberculosis, Bcgitis and off-label use: case report
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-82038-z

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Multiple drugs

Case report

Pantoprazole

Case report

Antineoplastics